Baumann Oliver Rolf (CIK 2129436) reported 1 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-31). Recent activity: Buy VRXA (50,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-31 | Veraxa Biotech AG - Post de-SPAC (VRXA) | Director | Buy | 50,000 | $75,000 |
来源：SEC Form 4 申报文件 · 截至 2026-08-31